Although more infectious diseases are spreading in the United States, top health officials on Sunday noted notes of optimism that the supply of both vaccines and the rate of vaccination would steadily increase.
The nation’s top infectious disease physician on the NBC program “Meet the Press”, Dr. Anthony S. Fauci has clearly demanded.
“I can tell you that things are going to get better, as we do in February to March, in April, because the number of vaccine doses that will be available will increase substantially.”
There has been a recent increase in the number of daily administered shots in the United States. Centers for Disease Control and Prevention Reported that over 2.2 million doses Were given on Saturday, and 1.6 million on Friday. This brought the latest seven-day average to 1.4 million per day, which approaches President Biden’s new goal 1.5 million shots per day.
In addition, the supply of vaccines – although still far below demand – is increasing. Union official Recently increased shipments The states receive 10.5 million doses a week, as Modern and Pfizer gradually increase production. The two companies have struck deals to supply the United States with a combined 400 million doses – enough to vaccinate 200 million people over the summer.
Pfizer recently said that it would now schedule its dosage two months before May, as it is now counting an additional dose in each vial to be manufactured. And Modern is considering a production change that would allow increasing the number of doses in its vials from 15 to 10.
Officials are also relying on the Food and Drug Administration, authorizing a one-dose vaccine from Johnson & Johnson later this month. Although that company will initially provide the United States with only a few million doses, production is expected to increase significantly by April. From other vaccines Novaxax And AstraZeneca could be authorized for US use in the spring, which would further increase supply.
Authorities are rushing to vaccinate more and more people to spread more infectious forms of the virus, first identified in Britain and South Africa. The UK version, known as B.1.1.7, is spreading rapidly in the United States, with its prevalence nearly doubling every 10 days, According to a new study. The CDC said it could become the dominant form of the virus in the United States by March.
While this variant is worrisome because it is more transmissible than the earlier variants, vaccine developers are more concerned about the variant discovered in South Africa, known as B.1.351, as it appears to be current. is Vaccines are less effective. Many manufacturers have stated that they were solving the problem by developing new versions of their vaccines, which could act as booster shots. The Food and Drug Administration has said that it is working on a plan to allow those new vaccine versions to be authorized.
AstraZeneca and Oxford University Vaccine Developers Said On Sunday, he hoped that a revised version of his vaccine would be available.
On the CBS program “Face the Nation”, former FDA commissioner and Pfizer’s board member Dr. Scott Gottlieb said on Sunday that he believed it would be possible to develop a booster that “we are seeing tied in a lot of variations.”
“I think there’s a fair chance that we’re going to be able to stay ahead of this virus,” he said.